Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Bausch Health Reaffirms FY21 Guidance: Adj. EBITDA $3.4B-$3.55B, Sales $8.6B-$8.8B vs $8.66B Estimate


Benzinga | May 4, 2021 07:07AM EDT

Bausch Health Reaffirms FY21 Guidance: Adj. EBITDA $3.4B-$3.55B, Sales $8.6B-$8.8B vs $8.66B Estimate






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC